Future Fund LLC’s Edwards Lifesciences EW Stock Holding History

Future Fund LLC’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.06M	Buy	25,677 +27	+0.1%	+$2.23K	0.72%	60
2025 Q4	$2.19M	Sell	25,650 -825	-3%	-$67.7K	0.69%	41
2025 Q3	$2.06M	Buy	26,475 +3,890	+17%	+$304K	0.73%	38
2025 Q2	$1.77M	Buy	22,585 +2,373	+12%	+$177K	0.79%	32
2025 Q1	$1.46M	Buy	20,212 +4,314	+27%	+$309K	1.88%	13
2024 Q4	$1.18M	Hold	15,898	–	–	3.36%	11
2024 Q3	$1.07M	Buy	15,898 +4,363	+38%	+$317K	3.1%	16
2024 Q2	$1.04M	Buy	11,535 +8,631	+297%	+$764K	2.61%	17
2024 Q1	$278K	Buy	+2,904	New	+$244K	2.25%	24

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Future Fund LLC's EW Position: Q1 2026 in Review

Future Fund LLC increased its Edwards Lifesciences (EW) stake by 0.11% in Q1 2026, buying an estimated $2.23K and bringing the position to 25,677 shares worth $2.06M. The position accounts for 0.72% of the portfolio, ranked #60.

Future Fund LLC first reported a position in EW in Q1 2024 and has held it in 9 quarters since. The position peaked at $2.19M in Q4 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Future Fund LLC held 25,677 shares of Edwards Lifesciences worth $2.06M as of Q1 2026.
Future Fund LLC bought 27 Edwards Lifesciences shares in Q1 2026, an estimated $2.23K.
Edwards Lifesciences made up 0.72% of Future Fund LLC's portfolio in Q1 2026, its #60 holding.
Future Fund LLC first reported a position in Edwards Lifesciences in Q1 2024 and has held it in 9 quarters since.
Future Fund LLC's Edwards Lifesciences position peaked at $2.19M in Q4 2025.
1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Future Fund LLC's 13F filing for Q1 2026, filed 6 May 2026.